Tumor-targeting core-shell structured nanoparticles for drug procedural controlled release and cancer sonodynamic combined therapy
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 286, 74-84
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81673021, 81572991, 81573151)
- Scientific and Technological Project of Henan Province (182102310117)
This publication has 38 references indexed in Scilit:
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE StudyLiver International, 2015
- Radiofrequency-Triggered Tumor-Targeting Delivery System for Theranostics ApplicationACS Applied Materials & Interfaces, 2015
- Potential sonodynamic anticancer activities of artemether and liposome-encapsulated artemetherChemical Communications, 2015
- The efficacy of Radachlorin-mediated photodynamic therapy in human hepatocellular carcinoma cellsJournal of Photochemistry and Photobiology B: Biology, 2015
- Biodegradable self-assembled nanoparticles of poly (d,l-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancerBiomaterials, 2014
- The characterization of an ultrasound spherical phased array for the ablation of deep-seated tissueApplied Acoustics, 2012
- Self-assembled nanoparticles of hyaluronic acid/poly(dl-lactide-co-glycolide) block copolymerColloids and Surfaces B: Biointerfaces, 2012
- Effect of thiol functionalization on the hemo‐compatibility of PLGA nanoparticlesJournal of Biomedical Materials Research Part A, 2011
- Artemisinin dimer anticancer activity correlates with heme‐catalyzed reactive oxygen species generation and endoplasmic reticulum stress inductionInternational Journal of Cancer, 2009
- Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugationInternational Journal of Pharmaceutics, 2008